CRP and metabolic dysfunction-associated steatotic liver disease: Similarly, conventional inflammatory biomarkers such as C-reactive protein (CRP), while associated with MASLD onset, have also shown limited accuracy in predicting critical pathological processes such as fibrosis progression (43).